Palantir Technologies Inc. (PLTR) — closed signal from October 17, 2025
Partial Published before the outcome was known, scored automatically when the window closed on January 15, 2026.
Predicted vs. what happened
What happened
Reached 70% of the predicted growth at its peak, without hitting the target.
The thesis — published October 17, 2025
Palantir is pausing after a big run but still leads in AI software. Recent news is positive, including a healthcare deal with OneMedNet that widens its potential customer base. The price has been trading in a tight range, and a move above $187 could attract more buyers. Momentum looks very low, which often precedes rebounds. Buying in steps aims for a return toward earlier highs over the next few months.
Primary drivers
- Short-term weakness within a strong, ongoing AI growth story
- OneMedNet deal opens more healthcare customers and new revenue paths
- Tight price range; a move above $187 could draw in fresh buyers
- Positive investor mood raises odds that gains can keep going
How it played out
PLTR: partial rally stopped short of target
Lyra published PLTR at $176.64 on 2025-10-17 with expected growth of 25%. The thesis pointed to short-term weakness inside a strong artificial intelligence software story, the OneMedNet healthcare deal, a tight trading range, and a possible move above $187 drawing in fresh buyers.
Inside the window, PLTR rose to a peak of $207.52 on 2025-11-03, a 17.5% gain. It stayed below the $220.80 target. By 2026-01-15, it ended at $177.07. The thesis partly played out because the stock did rally, but it never got there.
What happened during the window
On 2025-11-03, Palantir reported third-quarter revenue of $1.18 billion and raised its full-year revenue outlook to $4.396 billion to $4.4 billion. On 2025-11-03, Investopedia also reported that U.S. commercial revenue rose 121% to $397 million.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.